US20200337710A1 - Aneurysm device and delivery system - Google Patents

Aneurysm device and delivery system Download PDF

Info

Publication number
US20200337710A1
US20200337710A1 US16/924,571 US202016924571A US2020337710A1 US 20200337710 A1 US20200337710 A1 US 20200337710A1 US 202016924571 A US202016924571 A US 202016924571A US 2020337710 A1 US2020337710 A1 US 2020337710A1
Authority
US
United States
Prior art keywords
braid
segment
distal
aneurysm
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/924,571
Inventor
Juan Lorenzo
Lacey GOROCHOW
Ariel SOTO DEL VALLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Synthes Products Inc
Original Assignee
DePuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Synthes Products Inc filed Critical DePuy Synthes Products Inc
Priority to US16/924,571 priority Critical patent/US20200337710A1/en
Assigned to DePuy Synthes Products, Inc. reassignment DePuy Synthes Products, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOROCHOW, LACEY, SOTO DEL VALLE, ARIEL, LORENZO, JUAN
Publication of US20200337710A1 publication Critical patent/US20200337710A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027Type of occlusion
    • A61B17/12031Type of occlusion complete occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/361Image-producing devices, e.g. surgical cameras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/005Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12081Details concerning the detachment of the occluding device from the introduction device detachable by inflation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A61F2002/9665Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M2025/0042Microcatheters, cannula or the like having outside diameters around 1 mm or less

Definitions

  • This disclosure relates to medical instruments, and more particularly, delivery systems for aneurysm therapy.
  • Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels the corresponding limited treatment access.
  • occlusive devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems.
  • embolic coils that are delivered to the vasculature using microcatheter delivery systems.
  • a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure.
  • occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.
  • occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm as opposed to the volume of the aneurysm.
  • neck approaches, by minimizing blood flow across the neck, then a cessation of flow into the aneurysm may be achieved.
  • a thrombotic mass may naturally form without having to deliver embolic materials, as previously described.
  • embolic material since a natural mass can improve healing by reducing possible distention from arterial walls and permits reintegration into the original parent vessel shape along the neck plane of the aneurysm. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm.
  • neck-occlusive approaches are not without drawbacks. It is desired to block the neck of the aneurysm in the parent vessel. Further, embolic coils do not always effectively treat aneurysms as re-canalization of the aneurysm and/or coil compaction can occur over time.
  • the present disclosure relates to a self-expanding braid for treating an aneurysm.
  • the braid can include a lumen with a distal end opposite a proximal end. Translating the braid can cause the delivery portion to expand and form an occlusive sack as well as invert and fold into itself thereby for occluding an aneurysm.
  • an occlusive device for treating an aneurysm can include a delivery system and a braid being slideably disposed within the microcatheter in a collapsed state.
  • the braid can have a distal end opposite a proximal end.
  • the braid can include a distal segment between the distal and proximal ends.
  • the braid can be distally translatable from within the microcatheter to a deployed state.
  • the braid can expand to the deployed state as the distal end of the braid exits the microcatheter causing the distal segment to radially expand to form an occlusive sack for the aneurysm.
  • the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a porosity reduced relative to the occlusive sack thereby deflecting, diverting, and/or slowing a flow into the aneurysm.
  • the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a higher braid angle relative to the occlusive sack.
  • distally translating the braid after the occlusive sack is formed causes one or more segments proximal the distal segment to invert and tuck into the occlusive sack. In some embodiments, wherein the one or more segments proximal the distal segment have an increased braid angle relative to a braid angle of the distal segment to facilitate inversion.
  • the braid in the deployed state, is detachable from the delivery system in the aneurysm.
  • the delivery system can also include a delivery tube with a distal end and a proximal end. The distal end of the delivery tube can be detachably connected to the proximal end of the braid whereby the delivery tube can be translatably disposable within a microcatheter. The delivery tube can distally translate the braid within the microcatheter from the collapsed state to the deployed state.
  • the braid can include a tapered segment disposed between the distal segment and a proximal segment that can be elongate (e.g., partially, substantially, and/or entirely).
  • the tapered segment can have a tapered shape.
  • the proximal segment can be disposed on or adjacent the proximal end of the braid.
  • the occlusive sack of the distal segment can be spherical or any other shape adequate to occlude the aneurysm when in the deployed, expanded state.
  • the distal segment can form into the occlusive sack of the braid, which can be located at the neck of the aneurysm, by having the distal segment remain in place in the aneurysm, and the proximal segment translating distally, eventually inverting into the distal segment.
  • the occlusive sack can be capable of sealing the neck of the aneurysm.
  • the tapered segment is operable to cover the neck of the aneurysm and the proximal segment can be operable to tuck into the occlusive sack formed by the distal segment.
  • the tapered segment can divert flow or reduce the velocity of flow into the aneurysm.
  • the proximal segment can attach the braid to the distal end of the delivery tube and, after the distal segment has expanded to form the occlusive sack, can initiate inversion of the proximal end of the braid into the occlusive sack of the distal segment.
  • inverting the proximal end functions such as a tube sock into the distal segment.
  • the occlusive sack of the distal segment can be a collapsible cage-like vaso-occlusive structure.
  • the braid can include one or more buckle portions defined between the distal segment and the tapered and/or proximal segments.
  • the proximal end of the braid overlaid internal to the occlusive sack of the distal segment can be formed by inverting at the buckle portion, as the braid continues distally translating from the microcatheter and after the occlusive sack of the distal segment is formed by radial expansion.
  • the distal segment can also include fewer wire segments than the tapered and proximal segments.
  • each of the distal, tapered, and proximal segments can include different braid properties.
  • the tapered segment diverts flow as the distal segment forms the occlusive sack adjacent or is against a wall of the aneurysm and the proximal segment inverts into the distal segment at the neck of the aneurysm.
  • an imaging device operatively is in communication with the occlusive device, wherein the imaging device is capable of imaging the sack with respect to the aneurysm.
  • An orientation of the occlusive sack can be adjustable by the braid being distally or proximally moved.
  • a braid for treating an aneurysm can have a distal segment defined between proximal and distal ends of the braid.
  • the braid can also have a tapered segment disposed between the distal segment and an proximal segment.
  • the proximal segment can be disposed on or adjacent the proximal end.
  • the braid can be capable of moving from a collapsed state within a microcatheter to a deployed state external to the microcatheter.
  • translating the braid so the distal end is distal of the microcatheter causes the distal segment to radially expand and form an outer occlusive sack.
  • the occlusive sack can have a diameter greater than a diameter of the microcatheter.
  • translating the braid distally after the outer occlusive sack is formed can cause the tapered segment to invert into the occlusive sack.
  • the braid can be detachably deployable by a delivery system to an aneurysm.
  • the lumen of the braid can also include a buckle portion disposed between the distal segment and the tapered and/or proximal segments. The buckle portion can cause the tapered segment to invert into the occlusive sack.
  • a braid angle of the tapered segment can be adjusted (e.g., increased) compared to a braid angle of the distal segment.
  • a method of delivering an occlusive device to an aneurysm in a blood vessel in a patient can include slidably positioning a delivery tube within a microcatheter; slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end; selectively positioning the microcatheter, the delivery tube, and the braid into vasculature of the aneurysm; distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm; causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter; inverting a segment proximal the distal segment into the occlusive sack; and releasing
  • the inverting the segment proximal the distal segment into the occlusive sack can deflect, divert, and/or slow a flow into the aneurysm.
  • the method can include imaging the occlusive sack of the braid with respect to the aneurysm; determining whether the aneurysm is occluded by the sack; and distally or proximally sliding the braid to adjust the sack and to occlude the aneurysm.
  • the method can include adjusting (e.g., increasing) a braid angle of the proximal segment; positioning said segment adjacent or in communication with a neck of the aneurysm; and deflecting, diverting, and/or slowing a flow into the aneurysm when the proximal segment is inverted into the occlusive sack.
  • the method can include sealing, by the occlusive sack, the neck of the aneurysm.
  • the method can include positioning the distal segment across a neck of the aneurysm; and reducing the porosity of the distal segment relative to the occlusive sack.
  • the method can include positioning the distal segment across a neck of the aneurysm; and rendering higher a braid angle relative to the occlusive sack.
  • FIG. 1 depicts an example occlusive device of this disclosure deployed into an aneurysm
  • FIG. 2 is a schematic side view of an exemplary delivery system with an occlusive device in communication within a microcatheter;
  • FIG. 3 is an enlarged schematic side view of the braid of FIGS. 1-2 in an expanded state
  • FIG. 4A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 4B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 5A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 5B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 after the braid is deployed into an example aneurysm;
  • FIG. 6A is a perspective schematic view showing an exemplary delivery system for use with an example occlusive device
  • FIG. 6B is a perspective schematic view of FIG. 6A but with partial cross-section of the delivery system and the occlusive device;
  • FIG. 7A is a perspective schematic view of FIGS. 6A-6B being deployed with partial cross-section of the delivery system and the occlusive device;
  • FIG. 7B is a perspective schematic view of FIGS. 6A-6B deployed with the exemplary delivery system detached from the occlusive device;
  • FIG. 8 is a flow diagram for a method of delivering an occlusive device.
  • FIG. 9 is a flow diagram for a method of delivering an occlusive device.
  • vasculature of a “subject” or “patient” may be vasculature of a human or any animal.
  • an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc.
  • the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like).
  • the subject may be any applicable human patient, for example.
  • doctor may include a doctor, surgeon, or any other individual or delivery instrumentation associated with delivery of a braid body to the vasculature of a subject.
  • the occlusive device 1 and corresponding delivery system 40 disclosed here addresses the drawbacks of previous approaches.
  • FIG. 1 an example occlusive device 1 of this disclosure is shown deployed into an aneurysm A of blood vessel BV but not yet released from delivery system 40 .
  • the delivery system 40 can include a microcatheter 20 with a delivery tube 30 slideably disposed therein.
  • the microcatheter 20 has been delivered to the aneurysm A and an occlusive sack formed by distal segment 12 of braid 10 is shown forming a predetermined shape and structure that outlines and supports the walls of the aneurysm A so as to occlude aneurysm A.
  • Segment 12 can be formed on, with, or otherwise about distal end 14 of braid 10 .
  • the microcatheter 20 size is selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site.
  • the microcatheter 20 may have a total usable length anywhere from 80 centimeters to 170 centimeters.
  • the microcatheter 20 may have an inner diameter ID of anywhere between 0.015 and 0.032 inches.
  • the outer diameter OD may also range in size and may narrow at either its proximal end or distal end.
  • the microcatheter 20 may be attached to another device, and at its distal end 24 may be operable to positioned at the neck of the aneurysm A. While the distal end 24 of the microcatheter 20 as shown contains the braid 10 , the end 24 may be varied in shape and may curve at an angle.
  • System 40 can include a delivery tube 30 and a microcatheter 20 .
  • the delivery tube 30 can be capable of being distally pushed from a microcatheter 20 and the delivery tube 30 can have an inner lumen.
  • Delivery tube 30 can be substantially elongate and can extend from the proximal 26 to the distal end 24 of microcatheter 20 .
  • Tube 30 can generally run along the inner lumen of microcatheter 20 and may leave a space between its outer surface and the internal surface of microcatheter 20 .
  • delivery tube 30 and microcatheter 20 may be axially aligned.
  • System 40 can deliver braid 10 to a location of interest (e.g. a lesion site) using microcatheter 20 .
  • microcatheter 20 can be pre-placed at a level of the aneurysm neck and used to track the device 1 to the lesion.
  • Delivery tube 30 can be in mechanical connection with braid 10 at locking portion 54 .
  • Braid 10 may be attached to locking portion 54 by slidable attachment, permanent attachment (e.g. crimped, laser, ultrasonic weld, or other sources of heat, adhesive, or the like) or other detachable attachment approaches.
  • distally translating, sliding, or otherwise moving tube 30 towards the aneurysm A can cause braid 10 to begin moving from a collapsed condition within microcatheter 20 to a deployed condition external to microcatheter with occlusive sack of segment 12 , as discussed more particularly below.
  • the inner lumen of braid 10 can include a distal end 14 and a proximal end 16 .
  • the distal end 14 can be opened and/or be capable of allowing for sizing or conforming to the aneurysm A.
  • distal end 14 may be a closed end, whereas in a larger aneurysm the same braid 10 can have an open distal end 14 .
  • the inner lumen of braid 10 can be formed from a self-expanding and an invertible multi-filament outer surface that can includes a mesh.
  • the occlusive sack of braid 10 can be formed during deployment as distal end 14 of braid 10 slides out and exits microcatheter 20 .
  • the mesh of braid 10 can be defined by one or more mesh patterns with mesh openings defined by braided filaments.
  • the mesh of braid 10 can include a porosity region associated with the occlusive sack formed by braid 10 .
  • the mesh of braid 10 can be comprised of a tube of mesh, closed at one end (e.g. proximal end 16 ) and be made of several materials such as deposited thin films.
  • the self-expanding mesh of braid 10 can include multiple wires, for example from 4 to 96 wires. The number of wires can be a factor in controlling material properties of the braid 10 , including the stiffness.
  • the occlusive sack of braid 10 can be formed by braid 10 being distally translated from a collapsed state within microcatheter 20 and attached to delivery tube 30 .
  • the mesh of braid 10 is configured so that as braid 10 is distally translated and its end 14 exits from within microcatheter 20 , segment 12 will begin immediately expanding. As braid 10 is further translated, the segments of braid 10 , including segment 12 and its corresponding occlusive sack, will take shape. Fewer wires of the mesh of braid 10 can be used as a whole.
  • the wires can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, Platinum, Nitinol, Stainless Steel, Tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time.
  • the apertures in the mesh of braid 10 can also create a substantially unitary frame work or mesh.
  • the apertures may be of any size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 10 .
  • the apertures can provide the tubular element of braid 10 with flexibility and also assist in the transformation of the mesh from the collapsed state to the expanded, deployed state, and vice versa.
  • FIG. 3 an enlarged schematic side view of the braid 10 of FIGS. 1-2 is shown in a close-up, expanded state.
  • Other portions of the mesh of braid 10 can have different porosities and/or other material properties, including segments 11 and 13 of braid 10 .
  • the braid 10 can include several segments, including a generally spherical shaped segment associated with sack 12 along with a proximal tapered cone segment 13 leading to a relatively elongate proximal segment 11 .
  • Segment 11 of the braid 10 can have porosity less than the porosity of segment 13 and/or the segment of sack 12 .
  • the porosities associated with segments 11 , 12 , 13 and/or any other region or segment of braid 10 include filaments having modified braid angles at the different respective regions.
  • the braid angle can be modified by removing filaments in the respective region or by adding a coating or covering to a respective region or by selectively modifying the cross section of the wires.
  • Portions of braid 10 on or proximate end 16 may be more pliable that portions of braid 10 on or proximate end 14 in order to induce self-expansion during delivery and inversion as braid 10 forms its predetermined, sack-like shape within aneurysm A (see, e.g., segment 12 ).
  • the outer surface of braid 10 can also be made from nitinol with interwoven platinum filaments for radiopacity.
  • the tapered segment 13 adjacent to the spherical segment 12 can allow the braid 10 to invert on itself (like a sock) as the device 1 is fully deployed in the aneurysm A.
  • the braid 10 can be modified to weaken or make it more likely to invert.
  • segment 13 can include a buckle portion 17 that includes a localized braid angle change, removal of wire segments, localized heat treatment, and other approaches to change braid properties.
  • the braid angle of segment 13 can be increased relative to other portions of braid 10 so that the porosity of braid 10 across the neck is reduced so that a flow into the aneurysm is deflected, diverted, or slowed. This is because segment 13 can be in communication with the neck of the aneurysm when braid 10 is inverted and deployed in the aneurysm, since end 16 can be tucked into segment 12 (e.g., see FIG. 5B ).
  • a braid angle of one or some of the segments 11 , 12 , 13 of braid 10 can vary from the longitudinal axis of the braid 10 .
  • the wire diameter, pick count (i.e. the number of wire crossovers per lineal measurement) of braid 10 can also vary or otherwise be modified between segments of braid 10 to change the device characteristics.
  • the shape of braid 10 and any of its respective segments can also be heat set.
  • the fibers of braid 10 can be formed by being fastened at their free ends by heat bonding by laser or ultrasonic weld, solvent or adhesive binding, crimping, or any other attachment means.
  • the fibers of each segment of braid 10 may be bonded at their internal crossover points by solvent, adhesive, or heat bonding like laser, ultrasonic weld, or any other source of heat.
  • braid 10 is not so limited and it can have a braid angle, pitch count, wire diameter, porosity or any other property of braid 10 that is substantially similar throughout.
  • FIGS. 4A to 5B depict an enlarged schematic side view of the delivery system 40 and braid 10 as the braid 10 is being pushed into an example aneurysm A.
  • the mesh of braid 10 expands and then proximal end 16 inverts into braid 10 as the occlusive sack of segment 12 of braid 10 is formed. This means that braid 10 inverts along segment 11 in and rests inside of the aneurysm sack once deployed.
  • the inversion of the mesh of braid 10 can be formed when the end 14 of the braid 10 is relatively fixed against the wall of aneurysm A while end 16 is distally pushed forward away from microcatheter 20 and tucked into the sack of segment 12 .
  • proximal end 16 of braid 10 can begin inverting as the braid 10 moves distally forward as shown in FIG. 4B and braid 10 does not need for the entire length of 10 to be deployed before the braid starts inverting. In other embodiments, once the entire length of braid 10 is deployed and distal of microcatheter 20 , the proximal end 16 can invert and tuck into segment 12 . Regardless, in the deployed state, once selectively positioned and arranged in the proper deployed configuration with respect to aneurysm A, braid 10 can be detached. The inversion of braid 10 can be formed akin to a tube sock. In other embodiments, once the mesh of braid 10 is fully deployed and the occlusive sack of braid 10 is formed within aneurysm A, both the ends 14 , 16 can be next to or adjacent each other.
  • the braid 10 can be assembled with a delivery tube 30 and/or within a microcatheter 20 in a collapsed state.
  • the herein disclosed novel delivery system 40 and novel braid 10 can be packaged as a portable kit or system.
  • the assembly between microcatheter 20 , delivery tube 30 , and/or braid 10 can take place before being introduced into the vasculature.
  • the delivery system 40 used with braid 10 which can include microcatheter 20 and delivery tube 30 , can be selectively positioned at the lesion site and delivery tube 30 can begin distally translating braid 10 towards the aneurysm.
  • Braid 10 can expand as or upon its delivery end 14 contacting aneurysm A as it distally moves away from distal end 24 of catheter 20 to form the spherical sack associated with segment 12 within aneurysm A.
  • segment 12 of braid 10 is beginning to take a generally spherical shape internal to aneurysm A as braid 10 contacts dome D of aneurysm A and/or as braid is translated distally deeper into aneurysm A, further away from catheter 20 and tube 30 .
  • Delivery tube 30 may also include one or more fasteners operable to securely fasten braid 10 in place prior to deployment.
  • sack 12 can radially expand towards the outer walls of aneurysm A while unexpanded portions (e.g. segment 11 ) of braid 10 continue to be translated by delivery tube 30 .
  • delivery tube 30 distally moves further away from microcatheter 20 and braid 10 begins inverting as its end 16 continues moving distally, by delivery tube 30 , away from microcatheter 20 towards aneurysm A.
  • Delivery tube 30 may be driven by a hypotube from its proximal end 36 (not depicted) by an operator or the like.
  • Microcatheter 20 may remain relatively stationary or fixed while delivery tube 30 can be seen distally translating braid 10 towards and through the neck of aneurysm A.
  • Braid 10 can include a pre-weakened or buckle portion 17 so that as braid 10 and delivery tube 30 are distally translated away from microcatheter 20 and into aneurysm A, segment 11 can be translated causing radial expansion of segment 12 to form the corresponding occlusive sack. Continued distal translation of braid 10 can also cause the braid 10 to buckle and for end 16 to invert into sack of segment 12 .
  • portion 17 can initiate inversion of end 16 into segment 12 . Inverting end 16 into segment 12 is particularly advantageous as it prevents braid 10 from creating a protrusion that would otherwise extend into the parent vessel. Instead, any such protrusion is now inverted and tucked into segment 12 . Arranging braid 10 in this manner across the neck of the aneurysm, including by inverting end 16 into the sack of segment 12 , a flow diversion is created essentially inside of the sack of segment 12 .
  • buckle portion 17 may be formed into the interstices of braid 10 between end 14 of braid 10 and locking portion 54 between braid 10 and delivery tube 30 so that inversion occurs after braid 10 has distally translated a predetermined distance outside of delivery tube 30 .
  • Portion 17 may be simply a weak point or buckling point pre-set for a particular sack 12 so that buckling is induced so as to avoid strain of aneurysm A.
  • no buckle portion 17 may be included and instead braid 10 may invert and fold into itself upon end 14 of braid contacting the dome D of aneurism A (e.g. based on pre-selected pliability of braid 10 ).
  • Locking portion 54 , and/or portions of delivery tube 30 can be at the level of the neck of the aneurysm A as seen under fluoroscopy.
  • the outer diameter of the braid 10 about segment 12 radially expands to a diameter greater than the microcatheter 20 as the occlusive sack of segment 12 is formed.
  • the delivery system 40 can continue to be distally translated until the junction between end 16 of braid 10 , locking portion 54 , and delivery tube 30 is fully within the spherical, occlusive sack of segment 12 and inversion of braid 10 stops. Once braid 10 , segment 12 , and corresponding inversion of end 16 are selectively positioned and arranged to the desired condition (e.g.
  • braid 10 has been translated distally to expand segment 12 to form its sack and segments have been inverted therein), braid 10 can be detached from the delivery tube 30 as shown in FIG. 5B .
  • Delivery tube 30 between FIGS. 4A and 5A continues to distally slide braid 10 until in FIG. 5A , unexpanded, segments aft of segment 12 (e.g. segment 13 , segment 11 , or any other segments aft of segment 12 not depicted) invert and be tucked into the sack of segment 12 .
  • segments of braid 10 that are proximal of segment 12 can be used to force invert like a tube sock.
  • delivery tube 30 can be proximally translated back into microcatheter 20 and retracted from the braid 10 and aneurysm A.
  • the braid wire count of interstices of braid 10 that may form the outer surface of its expandable and invertible mesh can vary depending of the diameter of the sack of segment 12 and/or any sacks inverted internal thereto.
  • end 14 of braid 10 may be more pliable than the other end 16 , or vice versa, and other segments of braid 10 , including segments 11 , 12 , and 13 , may vary from most pliable on or about end 14 and less pliable on or about end 16 .
  • Interstices of braid 10 may also form openings for occlusion of the aneurysm.
  • an example spherical sack of segment 12 fully formed in a manner sufficient to occlude aneurysm A with one or more inverted portions disposed internal to the sack of segment 12 , braid 10 can be detached from locking portion 54 .
  • braid 10 including segment 12 , can be retracted back into delivery tube 30 by proximally withdrawing delivery tube 30 back into microcatheter 20 while still attached to braid 10 .
  • FIGS. 6A to 7B generally illustrate example attachment and delivery between delivery tube 30 and braid 10 for deploying and detaching braid 10 in aneurysm A.
  • the embodiments of FIGS. 6A to 7B is merely one way that delivery tube 30 and braid 10 may be attached at end 34 and any number of attachment means are contemplated as needed or required.
  • the delivery tube 30 as shown can have a lumen extending from a proximal end 36 to a distal, delivery end 34 .
  • FIG. 6A illustrates braid 10 engaged with the locking member 52 and loop wire 58 locked into the locking portion 54 .
  • the opening 60 of the loop wire 58 can be placed through the locking portion 54 .
  • the locking portion 54 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the locking portion 54 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. Locking member 52 , in one example, may be an elongated retractable fiber that may extend between ends 24 and 26 of the microcatheter 20 . Locking member 52 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable.
  • locking member 52 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable.
  • delivery tube 30 may include a compressible portion 38 disposed between its ends 34 and 36 .
  • the compressible portion 38 can allow the delivery tube 30 to bend and/or flex. Such flexibility can assist tracking the braid 10 through the microcatheter 20 and the tortuous path through the vasculature.
  • the compressible portion 38 can be formed with interference spiral cuts that can allow for gaps to permit bending but in one example, do not act as a spiral-cut spring.
  • Compressible portion 38 can be axially adjustable between an elongated condition and a compressed condition. However, any other arrangement allowing axial adjustment (e.g., a wound wire or spiral ribbon) can also be suitable for use with detachment systems according to the present disclosure).
  • the compressible portion 38 can be in the elongated condition at rest and automatically or resiliently returns to the elongated condition from a compressed condition, unless otherwise constrained. The function of the compressible portion 38 is described in greater detail herein.
  • FIG. 6A a force F was previously applied to place the delivery tube 30 in a compressed state.
  • FIG. 6B illustrates the locking member 52 being drawn proximally to begin the release sequence for braid 10 .
  • FIG. 7A illustrates the instant the locking member 52 exits the opening 60 and is pulled free of the loop wire 58 .
  • the distal end 62 of the loop wire 58 falls away/returns to its preformed shape and exits the locking portion 54 .
  • FIG. 7B illustrates the end of the release sequence.
  • the compressible portion 38 of the delivery tube 30 has expanded/returned to its original shape and “sprung” forward.
  • An elastic force E is imparted by the distal end 34 of the delivery tube 30 to the braid 10 to “push” it away to insure a clean separation and delivery of the braid 10 to the aneurysm A. It is to be understood that the delivery scheme described in FIGS. 6A-7B are merely example approaches to delivery of braid 10 .
  • FIG. 8 is a flow diagram for a method 800 of delivering an occlusive device.
  • Step 805 includes positioning an occlusive device within a microcatheter and in communication with a delivery tube, the occlusive device including a braid capable of expanding and inverting into itself.
  • Step 810 includes distally sliding, by the delivery tube, the braid from the microcatheter.
  • Step 815 includes radially expanding, as the braid distally exits the microcatheter, a distal segment of the braid between proximal and distal ends of the braid to form an occlusive sack within the aneurysm.
  • Step 820 includes inverting the proximal end of the braid into the occlusive sack.
  • Step 825 includes detaching the braid from the delivery tube and withdrawing the delivery tube from the aneurysm.
  • FIG. 9 is a flow diagram for a method 900 of delivering an occlusive device.
  • Step 905 includes slidably positioning a delivery tube within a microcatheter.
  • Step 910 includes slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end. This step can also include detachably attaching the proximal end of the braid to the distal end of the delivery tube.
  • Step 915 includes selectively positioning the microcatheter, the delivery tube, and the braid into the vasculature of the aneurysm.
  • Step 920 includes distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm.
  • Step 925 includes causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter.
  • Step 930 includes inverting and/or tucking a proximal segment into the occlusive sack.
  • Step 935 includes releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm and the vasculature.
  • variations of the braid 10 can include various materials such as nitinol, stainless steel, bio absorbable materials, and polymers. Braid 10 , including any specific portions such as any breaks and corresponding sacks, can be heat set to various configurations such as spherical, oblong, saddle shaped, etc. for the purpose of shaping the initial sack to better match the aneurysm morphology. In addition, the braid 10 can be heat shaped to include weak points to facility the braid buckling once it reaches the dome of the aneurysm.
  • any sack formed by the herein discussed braids 10 can be in a spherical shape as depicted or any other shape, as needed or required, such as ellipsoidal, heart-shaped, ovoid, cylindrical, hemispherical, or the like. Further, interstices of braid 10 that form the sack can vary, or be selectively designed, in size or shape along its length depending on how much braid 10 is caused to radially expand as delivery tube 30 is distally moved.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Surgical Instruments (AREA)

Abstract

The present disclosure relates to a self-expanding braid for treating an aneurysm. The braid can include a lumen with a proximal end opposite a distal end. Translating the braid can cause a distal segment of the braid to expand and form an outer occlusive sack while a segment proximal the distal segment can invert into the outer occlusive sack like a tube sock. The braid can then be detached from its delivery system.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is a Continuation of U.S. patent application Ser. No. 15/852,887 filed Dec. 22, 2017, the contents which are herein incorporated by reference.
  • FIELD
  • This disclosure relates to medical instruments, and more particularly, delivery systems for aneurysm therapy.
  • BACKGROUND
  • Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels the corresponding limited treatment access.
  • Prior solutions have included endovascular treatment access whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. In this respect, because the interior walls of the aneurysm may continue being subjected to flow of blood and related pressure, aneurysm rupture remains possible.
  • Alternative to endovascular or other surgical approaches can include occlusive devices. Such devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems. For example, when treating cranial aneurysms, a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure. However, such occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.
  • One particular type of occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm as opposed to the volume of the aneurysm. In such “neck” approaches, by minimizing blood flow across the neck, then a cessation of flow into the aneurysm may be achieved. In turn, a thrombotic mass may naturally form without having to deliver embolic materials, as previously described. This is preferable to masses formed from embolic material since a natural mass can improve healing by reducing possible distention from arterial walls and permits reintegration into the original parent vessel shape along the neck plane of the aneurysm. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm. However, neck-occlusive approaches are not without drawbacks. It is desired to block the neck of the aneurysm in the parent vessel. Further, embolic coils do not always effectively treat aneurysms as re-canalization of the aneurysm and/or coil compaction can occur over time.
  • The solution of this disclosure resolves these and other issues of the art.
  • SUMMARY
  • In some aspects, the present disclosure relates to a self-expanding braid for treating an aneurysm. The braid can include a lumen with a distal end opposite a proximal end. Translating the braid can cause the delivery portion to expand and form an occlusive sack as well as invert and fold into itself thereby for occluding an aneurysm.
  • In certain embodiments, an occlusive device for treating an aneurysm is provided. The device can include a delivery system and a braid being slideably disposed within the microcatheter in a collapsed state. The braid can have a distal end opposite a proximal end. The braid can include a distal segment between the distal and proximal ends. The braid can be distally translatable from within the microcatheter to a deployed state. The braid can expand to the deployed state as the distal end of the braid exits the microcatheter causing the distal segment to radially expand to form an occlusive sack for the aneurysm.
  • In some embodiments, the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a porosity reduced relative to the occlusive sack thereby deflecting, diverting, and/or slowing a flow into the aneurysm.
  • In some embodiments, the distal segment is capable of being disposed across the aneurysm neck, wherein the distal segment can include a higher braid angle relative to the occlusive sack.
  • In some embodiments, distally translating the braid after the occlusive sack is formed causes one or more segments proximal the distal segment to invert and tuck into the occlusive sack. In some embodiments, wherein the one or more segments proximal the distal segment have an increased braid angle relative to a braid angle of the distal segment to facilitate inversion. In some embodiments, in the deployed state, the braid is detachable from the delivery system in the aneurysm. The delivery system can also include a delivery tube with a distal end and a proximal end. The distal end of the delivery tube can be detachably connected to the proximal end of the braid whereby the delivery tube can be translatably disposable within a microcatheter. The delivery tube can distally translate the braid within the microcatheter from the collapsed state to the deployed state.
  • In some embodiments, the braid can include a tapered segment disposed between the distal segment and a proximal segment that can be elongate (e.g., partially, substantially, and/or entirely). The tapered segment can have a tapered shape. The proximal segment can be disposed on or adjacent the proximal end of the braid. The occlusive sack of the distal segment can be spherical or any other shape adequate to occlude the aneurysm when in the deployed, expanded state. The distal segment can form into the occlusive sack of the braid, which can be located at the neck of the aneurysm, by having the distal segment remain in place in the aneurysm, and the proximal segment translating distally, eventually inverting into the distal segment. The occlusive sack can be capable of sealing the neck of the aneurysm. In some embodiments, the tapered segment is operable to cover the neck of the aneurysm and the proximal segment can be operable to tuck into the occlusive sack formed by the distal segment. The tapered segment can divert flow or reduce the velocity of flow into the aneurysm. The proximal segment can attach the braid to the distal end of the delivery tube and, after the distal segment has expanded to form the occlusive sack, can initiate inversion of the proximal end of the braid into the occlusive sack of the distal segment. In one embodiment, inverting the proximal end functions such as a tube sock into the distal segment.
  • In some embodiments, the occlusive sack of the distal segment can be a collapsible cage-like vaso-occlusive structure. In some embodiment, the braid can include one or more buckle portions defined between the distal segment and the tapered and/or proximal segments. In this regard, the proximal end of the braid overlaid internal to the occlusive sack of the distal segment can be formed by inverting at the buckle portion, as the braid continues distally translating from the microcatheter and after the occlusive sack of the distal segment is formed by radial expansion. The distal segment can also include fewer wire segments than the tapered and proximal segments.
  • In some embodiments, each of the distal, tapered, and proximal segments can include different braid properties.
  • In some embodiments, the tapered segment diverts flow as the distal segment forms the occlusive sack adjacent or is against a wall of the aneurysm and the proximal segment inverts into the distal segment at the neck of the aneurysm.
  • In some embodiments, an imaging device operatively is in communication with the occlusive device, wherein the imaging device is capable of imaging the sack with respect to the aneurysm. An orientation of the occlusive sack can be adjustable by the braid being distally or proximally moved.
  • In some embodiments, a braid for treating an aneurysm is provided. The braid can have a distal segment defined between proximal and distal ends of the braid. The braid can also have a tapered segment disposed between the distal segment and an proximal segment. The proximal segment can be disposed on or adjacent the proximal end. The braid can be capable of moving from a collapsed state within a microcatheter to a deployed state external to the microcatheter. In this embodiment, translating the braid so the distal end is distal of the microcatheter causes the distal segment to radially expand and form an outer occlusive sack. The occlusive sack can have a diameter greater than a diameter of the microcatheter. Additionally, translating the braid distally after the outer occlusive sack is formed can cause the tapered segment to invert into the occlusive sack.
  • In some embodiments, the braid can be detachably deployable by a delivery system to an aneurysm. The lumen of the braid can also include a buckle portion disposed between the distal segment and the tapered and/or proximal segments. The buckle portion can cause the tapered segment to invert into the occlusive sack. In some embodiments, a braid angle of the tapered segment can be adjusted (e.g., increased) compared to a braid angle of the distal segment.
  • In some embodiments, a method of delivering an occlusive device to an aneurysm in a blood vessel in a patient is disclosed. The method can include slidably positioning a delivery tube within a microcatheter; slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end; selectively positioning the microcatheter, the delivery tube, and the braid into vasculature of the aneurysm; distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm; causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter; inverting a segment proximal the distal segment into the occlusive sack; and releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm.
  • In some embodiments, the inverting the segment proximal the distal segment into the occlusive sack can deflect, divert, and/or slow a flow into the aneurysm.
  • In some embodiments, the method can include imaging the occlusive sack of the braid with respect to the aneurysm; determining whether the aneurysm is occluded by the sack; and distally or proximally sliding the braid to adjust the sack and to occlude the aneurysm.
  • In some embodiments, the method can include adjusting (e.g., increasing) a braid angle of the proximal segment; positioning said segment adjacent or in communication with a neck of the aneurysm; and deflecting, diverting, and/or slowing a flow into the aneurysm when the proximal segment is inverted into the occlusive sack.
  • In some embodiments, the method can include sealing, by the occlusive sack, the neck of the aneurysm.
  • In some embodiments, the method can include positioning the distal segment across a neck of the aneurysm; and reducing the porosity of the distal segment relative to the occlusive sack.
  • In some embodiments, the method can include positioning the distal segment across a neck of the aneurysm; and rendering higher a braid angle relative to the occlusive sack.
  • Other aspects and features of the present disclosure will become apparent to those of ordinary skill in the art, upon reviewing the following detailed description in conjunction with the accompanying figures.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Reference will now be made to the accompanying drawings, which are not necessarily drawn to scale.
  • FIG. 1 depicts an example occlusive device of this disclosure deployed into an aneurysm;
  • FIG. 2 is a schematic side view of an exemplary delivery system with an occlusive device in communication within a microcatheter;
  • FIG. 3 is an enlarged schematic side view of the braid of FIGS. 1-2 in an expanded state;
  • FIG. 4A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 4B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 5A is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 as the braid is being pushed into an example aneurysm;
  • FIG. 5B is an enlarged schematic side view of the delivery system and braid of FIGS. 1-3 after the braid is deployed into an example aneurysm;
  • FIG. 6A is a perspective schematic view showing an exemplary delivery system for use with an example occlusive device;
  • FIG. 6B is a perspective schematic view of FIG. 6A but with partial cross-section of the delivery system and the occlusive device;
  • FIG. 7A is a perspective schematic view of FIGS. 6A-6B being deployed with partial cross-section of the delivery system and the occlusive device;
  • FIG. 7B is a perspective schematic view of FIGS. 6A-6B deployed with the exemplary delivery system detached from the occlusive device;
  • FIG. 8 is a flow diagram for a method of delivering an occlusive device; and
  • FIG. 9 is a flow diagram for a method of delivering an occlusive device.
  • DETAILED DESCRIPTION
  • Although example embodiments of the disclosed technology are explained in detail herein, it is to be understood that other embodiments are contemplated. Accordingly, it is not intended that the disclosed technology be limited in its scope to the details of construction and arrangement of components set forth in the following description or illustrated in the drawings. The disclosed technology is capable of other embodiments and of being practiced or carried out in various ways.
  • It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. By “comprising” or “containing” or “including” it is meant that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if the other such compounds, material, particles, method steps have the same function as what is named.
  • In describing example embodiments, terminology will be resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Steps of a method may be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that the mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified.
  • As discussed herein, vasculature of a “subject” or “patient” may be vasculature of a human or any animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like). It should be appreciated that the subject may be any applicable human patient, for example.
  • As discussed herein, “operator” may include a doctor, surgeon, or any other individual or delivery instrumentation associated with delivery of a braid body to the vasculature of a subject.
  • The occlusive device 1 and corresponding delivery system 40 disclosed here addresses the drawbacks of previous approaches. Turning to FIG. 1, an example occlusive device 1 of this disclosure is shown deployed into an aneurysm A of blood vessel BV but not yet released from delivery system 40. The delivery system 40 can include a microcatheter 20 with a delivery tube 30 slideably disposed therein. In FIG. 1, the microcatheter 20 has been delivered to the aneurysm A and an occlusive sack formed by distal segment 12 of braid 10 is shown forming a predetermined shape and structure that outlines and supports the walls of the aneurysm A so as to occlude aneurysm A. Segment 12 can be formed on, with, or otherwise about distal end 14 of braid 10. The microcatheter 20 size is selected in consideration of the size, shape, and directionality of the aneurysm or the body lumens the catheter must pass through to get to the treatment site. The microcatheter 20 may have a total usable length anywhere from 80 centimeters to 170 centimeters. The microcatheter 20 may have an inner diameter ID of anywhere between 0.015 and 0.032 inches. The outer diameter OD may also range in size and may narrow at either its proximal end or distal end. At its proximal end 26, the microcatheter 20 may be attached to another device, and at its distal end 24 may be operable to positioned at the neck of the aneurysm A. While the distal end 24 of the microcatheter 20 as shown contains the braid 10, the end 24 may be varied in shape and may curve at an angle.
  • Turning to FIG. 2, a schematic side view of braid 10 and delivery system 40 is shown in a deployed configuration but prior to being positioned in a location of interest in the vasculature. System 40 can include a delivery tube 30 and a microcatheter 20. The delivery tube 30 can be capable of being distally pushed from a microcatheter 20 and the delivery tube 30 can have an inner lumen. Delivery tube 30 can be substantially elongate and can extend from the proximal 26 to the distal end 24 of microcatheter 20. Tube 30 can generally run along the inner lumen of microcatheter 20 and may leave a space between its outer surface and the internal surface of microcatheter 20. In turn, delivery tube 30 and microcatheter 20 may be axially aligned. System 40 can deliver braid 10 to a location of interest (e.g. a lesion site) using microcatheter 20. In certain embodiments, microcatheter 20 can be pre-placed at a level of the aneurysm neck and used to track the device 1 to the lesion. Delivery tube 30 can be in mechanical connection with braid 10 at locking portion 54. Braid 10 may be attached to locking portion 54 by slidable attachment, permanent attachment (e.g. crimped, laser, ultrasonic weld, or other sources of heat, adhesive, or the like) or other detachable attachment approaches. When delivery tube 30 is mechanically attached to braid 10 at locking portion 54, distally translating, sliding, or otherwise moving tube 30 towards the aneurysm A can cause braid 10 to begin moving from a collapsed condition within microcatheter 20 to a deployed condition external to microcatheter with occlusive sack of segment 12, as discussed more particularly below.
  • The inner lumen of braid 10 can include a distal end 14 and a proximal end 16. The distal end 14 can be opened and/or be capable of allowing for sizing or conforming to the aneurysm A. For example, if the aneurysm is relatively small, distal end 14 may be a closed end, whereas in a larger aneurysm the same braid 10 can have an open distal end 14. The inner lumen of braid 10 can be formed from a self-expanding and an invertible multi-filament outer surface that can includes a mesh. The occlusive sack of braid 10 can be formed during deployment as distal end 14 of braid 10 slides out and exits microcatheter 20. The mesh of braid 10 can be defined by one or more mesh patterns with mesh openings defined by braided filaments. For example, the mesh of braid 10 can include a porosity region associated with the occlusive sack formed by braid 10. The mesh of braid 10 can be comprised of a tube of mesh, closed at one end (e.g. proximal end 16) and be made of several materials such as deposited thin films. The self-expanding mesh of braid 10 can include multiple wires, for example from 4 to 96 wires. The number of wires can be a factor in controlling material properties of the braid 10, including the stiffness.
  • The occlusive sack of braid 10 can be formed by braid 10 being distally translated from a collapsed state within microcatheter 20 and attached to delivery tube 30. The mesh of braid 10 is configured so that as braid 10 is distally translated and its end 14 exits from within microcatheter 20, segment 12 will begin immediately expanding. As braid 10 is further translated, the segments of braid 10, including segment 12 and its corresponding occlusive sack, will take shape. Fewer wires of the mesh of braid 10 can be used as a whole. The wires can be made from multiple alloys such as a nickel-titanium alloy, cobalt chromium alloys, Platinum, Nitinol, Stainless Steel, Tantalum, or other alloys, or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time.
  • The apertures in the mesh of braid 10 can also create a substantially unitary frame work or mesh. Thus, the apertures may be of any size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 10. The apertures can provide the tubular element of braid 10 with flexibility and also assist in the transformation of the mesh from the collapsed state to the expanded, deployed state, and vice versa.
  • Turning to FIG. 3, an enlarged schematic side view of the braid 10 of FIGS. 1-2 is shown in a close-up, expanded state. Other portions of the mesh of braid 10 can have different porosities and/or other material properties, including segments 11 and 13 of braid 10. The braid 10 can include several segments, including a generally spherical shaped segment associated with sack 12 along with a proximal tapered cone segment 13 leading to a relatively elongate proximal segment 11. Segment 11 of the braid 10 can have porosity less than the porosity of segment 13 and/or the segment of sack 12. The porosities associated with segments 11, 12, 13 and/or any other region or segment of braid 10 include filaments having modified braid angles at the different respective regions. For example, the braid angle can be modified by removing filaments in the respective region or by adding a coating or covering to a respective region or by selectively modifying the cross section of the wires. Portions of braid 10 on or proximate end 16 may be more pliable that portions of braid 10 on or proximate end 14 in order to induce self-expansion during delivery and inversion as braid 10 forms its predetermined, sack-like shape within aneurysm A (see, e.g., segment 12). The outer surface of braid 10 can also be made from nitinol with interwoven platinum filaments for radiopacity. The tapered segment 13 adjacent to the spherical segment 12 can allow the braid 10 to invert on itself (like a sock) as the device 1 is fully deployed in the aneurysm A. To facilitate inversion of the braid 10 in the segment 13, the braid 10 can be modified to weaken or make it more likely to invert. For example, segment 13 can include a buckle portion 17 that includes a localized braid angle change, removal of wire segments, localized heat treatment, and other approaches to change braid properties. In certain embodiments, the braid angle of segment 13 can be increased relative to other portions of braid 10 so that the porosity of braid 10 across the neck is reduced so that a flow into the aneurysm is deflected, diverted, or slowed. This is because segment 13 can be in communication with the neck of the aneurysm when braid 10 is inverted and deployed in the aneurysm, since end 16 can be tucked into segment 12 (e.g., see FIG. 5B).
  • In certain embodiments, a braid angle of one or some of the segments 11, 12, 13 of braid 10 can vary from the longitudinal axis of the braid 10. The wire diameter, pick count (i.e. the number of wire crossovers per lineal measurement) of braid 10 can also vary or otherwise be modified between segments of braid 10 to change the device characteristics. The shape of braid 10 and any of its respective segments can also be heat set. The fibers of braid 10 can be formed by being fastened at their free ends by heat bonding by laser or ultrasonic weld, solvent or adhesive binding, crimping, or any other attachment means. The fibers of each segment of braid 10 may be bonded at their internal crossover points by solvent, adhesive, or heat bonding like laser, ultrasonic weld, or any other source of heat. However, braid 10 is not so limited and it can have a braid angle, pitch count, wire diameter, porosity or any other property of braid 10 that is substantially similar throughout.
  • FIGS. 4A to 5B depict an enlarged schematic side view of the delivery system 40 and braid 10 as the braid 10 is being pushed into an example aneurysm A. The mesh of braid 10 expands and then proximal end 16 inverts into braid 10 as the occlusive sack of segment 12 of braid 10 is formed. This means that braid 10 inverts along segment 11 in and rests inside of the aneurysm sack once deployed. In one example, the inversion of the mesh of braid 10 can be formed when the end 14 of the braid 10 is relatively fixed against the wall of aneurysm A while end 16 is distally pushed forward away from microcatheter 20 and tucked into the sack of segment 12. In certain embodiments, proximal end 16 of braid 10 can begin inverting as the braid 10 moves distally forward as shown in FIG. 4B and braid 10 does not need for the entire length of 10 to be deployed before the braid starts inverting. In other embodiments, once the entire length of braid 10 is deployed and distal of microcatheter 20, the proximal end 16 can invert and tuck into segment 12. Regardless, in the deployed state, once selectively positioned and arranged in the proper deployed configuration with respect to aneurysm A, braid 10 can be detached. The inversion of braid 10 can be formed akin to a tube sock. In other embodiments, once the mesh of braid 10 is fully deployed and the occlusive sack of braid 10 is formed within aneurysm A, both the ends 14, 16 can be next to or adjacent each other.
  • Prior to the arrangement of FIG. 4A, the braid 10 can be assembled with a delivery tube 30 and/or within a microcatheter 20 in a collapsed state. In this respect, the herein disclosed novel delivery system 40 and novel braid 10 can be packaged as a portable kit or system. The assembly between microcatheter 20, delivery tube 30, and/or braid 10 can take place before being introduced into the vasculature. The delivery system 40 used with braid 10, which can include microcatheter 20 and delivery tube 30, can be selectively positioned at the lesion site and delivery tube 30 can begin distally translating braid 10 towards the aneurysm. Braid 10 can expand as or upon its delivery end 14 contacting aneurysm A as it distally moves away from distal end 24 of catheter 20 to form the spherical sack associated with segment 12 within aneurysm A. As shown in FIG. 4A, segment 12 of braid 10 is beginning to take a generally spherical shape internal to aneurysm A as braid 10 contacts dome D of aneurysm A and/or as braid is translated distally deeper into aneurysm A, further away from catheter 20 and tube 30. Delivery tube 30 may also include one or more fasteners operable to securely fasten braid 10 in place prior to deployment.
  • As shown in FIG. 4A, sack 12 can radially expand towards the outer walls of aneurysm A while unexpanded portions (e.g. segment 11) of braid 10 continue to be translated by delivery tube 30. In FIG. 4B, delivery tube 30 distally moves further away from microcatheter 20 and braid 10 begins inverting as its end 16 continues moving distally, by delivery tube 30, away from microcatheter 20 towards aneurysm A. Delivery tube 30 may be driven by a hypotube from its proximal end 36 (not depicted) by an operator or the like. Microcatheter 20 may remain relatively stationary or fixed while delivery tube 30 can be seen distally translating braid 10 towards and through the neck of aneurysm A. Braid 10 can include a pre-weakened or buckle portion 17 so that as braid 10 and delivery tube 30 are distally translated away from microcatheter 20 and into aneurysm A, segment 11 can be translated causing radial expansion of segment 12 to form the corresponding occlusive sack. Continued distal translation of braid 10 can also cause the braid 10 to buckle and for end 16 to invert into sack of segment 12. In certain embodiments, portion 17 can initiate inversion of end 16 into segment 12. Inverting end 16 into segment 12 is particularly advantageous as it prevents braid 10 from creating a protrusion that would otherwise extend into the parent vessel. Instead, any such protrusion is now inverted and tucked into segment 12. Arranging braid 10 in this manner across the neck of the aneurysm, including by inverting end 16 into the sack of segment 12, a flow diversion is created essentially inside of the sack of segment 12.
  • It is understood that buckle portion 17 may be formed into the interstices of braid 10 between end 14 of braid 10 and locking portion 54 between braid 10 and delivery tube 30 so that inversion occurs after braid 10 has distally translated a predetermined distance outside of delivery tube 30. Portion 17 may be simply a weak point or buckling point pre-set for a particular sack 12 so that buckling is induced so as to avoid strain of aneurysm A. Alternatively, no buckle portion 17 may be included and instead braid 10 may invert and fold into itself upon end 14 of braid contacting the dome D of aneurism A (e.g. based on pre-selected pliability of braid 10).
  • Locking portion 54, and/or portions of delivery tube 30 can be at the level of the neck of the aneurysm A as seen under fluoroscopy. In moving between FIGS. 4A-5B, the outer diameter of the braid 10 about segment 12 radially expands to a diameter greater than the microcatheter 20 as the occlusive sack of segment 12 is formed. In FIG. 5A, the delivery system 40 can continue to be distally translated until the junction between end 16 of braid 10, locking portion 54, and delivery tube 30 is fully within the spherical, occlusive sack of segment 12 and inversion of braid 10 stops. Once braid 10, segment 12, and corresponding inversion of end 16 are selectively positioned and arranged to the desired condition (e.g. braid 10 has been translated distally to expand segment 12 to form its sack and segments have been inverted therein), braid 10 can be detached from the delivery tube 30 as shown in FIG. 5B. Delivery tube 30 between FIGS. 4A and 5A continues to distally slide braid 10 until in FIG. 5A, unexpanded, segments aft of segment 12 (e.g. segment 13, segment 11, or any other segments aft of segment 12 not depicted) invert and be tucked into the sack of segment 12. In other words, as the braid 10 is distally translated towards the dome of the aneurysm A, the segments of braid 10 that are proximal of segment 12 can be used to force invert like a tube sock. In turn, delivery tube 30 can be proximally translated back into microcatheter 20 and retracted from the braid 10 and aneurysm A.
  • The braid wire count of interstices of braid 10 that may form the outer surface of its expandable and invertible mesh can vary depending of the diameter of the sack of segment 12 and/or any sacks inverted internal thereto. For example, in order to induce formation of the predetermined shape and strength of the occlusive sack of segment 12, end 14 of braid 10 may be more pliable than the other end 16, or vice versa, and other segments of braid 10, including segments 11, 12, and 13, may vary from most pliable on or about end 14 and less pliable on or about end 16. Interstices of braid 10 may also form openings for occlusion of the aneurysm.
  • In FIG. 5B, an example spherical sack of segment 12 fully formed in a manner sufficient to occlude aneurysm A with one or more inverted portions disposed internal to the sack of segment 12, braid 10 can be detached from locking portion 54. However, if the sack of segment 12 is not precisely positioned or if segment 12 and/or any internally disposed segments formed by inversion of segments proximal thereto need to be reset or adjusted within aneurysm A for safe occlusion without risk of rupture, braid 10, including segment 12, can be retracted back into delivery tube 30 by proximally withdrawing delivery tube 30 back into microcatheter 20 while still attached to braid 10. In FIG. 5B, since the sack of segment 12 has been selectively positioned and formed within aneurysm A, braid 10 has been detached from delivery tube 30 and delivery tube 30 and microcatheter 20 can now be retraced from aneurysm A and the lesion site. It is understood that some or all of locking portion 54 can be formed with the microcatheter 20 or delivery tube 30 and/or can be radiopaque so that positioning and detachment can be monitored and/or driven under fluoroscopy.
  • FIGS. 6A to 7B generally illustrate example attachment and delivery between delivery tube 30 and braid 10 for deploying and detaching braid 10 in aneurysm A. The embodiments of FIGS. 6A to 7B is merely one way that delivery tube 30 and braid 10 may be attached at end 34 and any number of attachment means are contemplated as needed or required. The delivery tube 30 as shown can have a lumen extending from a proximal end 36 to a distal, delivery end 34. FIG. 6A illustrates braid 10 engaged with the locking member 52 and loop wire 58 locked into the locking portion 54. The opening 60 of the loop wire 58 can be placed through the locking portion 54. The locking portion 54 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the locking portion 54 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. Locking member 52, in one example, may be an elongated retractable fiber that may extend between ends 24 and 26 of the microcatheter 20. Locking member 52 preferably takes the form of a small diameter elongate filament, however, other forms such as wires or tubular structures are also suitable. While the locking member 52 is preferably formed of nitinol, other metals and materials such as stainless steel, PTFE, nylon, ceramic or glass fiber and composites may also be suitable. When the locking member 52 is put through the opening 60 the braid 10 is now secure. It is understood that delivery tube 30 may include a compressible portion 38 disposed between its ends 34 and 36.
  • The compressible portion 38 can allow the delivery tube 30 to bend and/or flex. Such flexibility can assist tracking the braid 10 through the microcatheter 20 and the tortuous path through the vasculature. The compressible portion 38 can be formed with interference spiral cuts that can allow for gaps to permit bending but in one example, do not act as a spiral-cut spring. Compressible portion 38 can be axially adjustable between an elongated condition and a compressed condition. However, any other arrangement allowing axial adjustment (e.g., a wound wire or spiral ribbon) can also be suitable for use with detachment systems according to the present disclosure). The compressible portion 38 can be in the elongated condition at rest and automatically or resiliently returns to the elongated condition from a compressed condition, unless otherwise constrained. The function of the compressible portion 38 is described in greater detail herein.
  • In FIG. 6A, a force F was previously applied to place the delivery tube 30 in a compressed state. FIG. 6B illustrates the locking member 52 being drawn proximally to begin the release sequence for braid 10. FIG. 7A illustrates the instant the locking member 52 exits the opening 60 and is pulled free of the loop wire 58. The distal end 62 of the loop wire 58 falls away/returns to its preformed shape and exits the locking portion 54. As can be seen, there is now nothing holding the braid 10 to the delivery tube 30. FIG. 7B illustrates the end of the release sequence. Here, the compressible portion 38 of the delivery tube 30 has expanded/returned to its original shape and “sprung” forward. An elastic force E is imparted by the distal end 34 of the delivery tube 30 to the braid 10 to “push” it away to insure a clean separation and delivery of the braid 10 to the aneurysm A. It is to be understood that the delivery scheme described in FIGS. 6A-7B are merely example approaches to delivery of braid 10.
  • FIG. 8 is a flow diagram for a method 800 of delivering an occlusive device. Step 805 includes positioning an occlusive device within a microcatheter and in communication with a delivery tube, the occlusive device including a braid capable of expanding and inverting into itself. Step 810 includes distally sliding, by the delivery tube, the braid from the microcatheter. Step 815 includes radially expanding, as the braid distally exits the microcatheter, a distal segment of the braid between proximal and distal ends of the braid to form an occlusive sack within the aneurysm. Step 820 includes inverting the proximal end of the braid into the occlusive sack. Step 825 includes detaching the braid from the delivery tube and withdrawing the delivery tube from the aneurysm.
  • FIG. 9 is a flow diagram for a method 900 of delivering an occlusive device. Step 905 includes slidably positioning a delivery tube within a microcatheter. Step 910 includes slidably positioning a braid with the delivery tube, the braid being in a collapsed state and comprising a distal end and a proximal end. This step can also include detachably attaching the proximal end of the braid to the distal end of the delivery tube. Step 915 includes selectively positioning the microcatheter, the delivery tube, and the braid into the vasculature of the aneurysm. Step 920 includes distally sliding the braid, by the delivery tube, from the microcatheter towards the aneurysm. Step 925 includes causing a distal segment between the proximal and distal ends of the braid to move from the collapsed state within the microcatheter to a deployed stated defined by the distal segment radially expanding to form an occlusive sack as the distal end of the braid is moved distally from the microcatheter. Step 930 includes inverting and/or tucking a proximal segment into the occlusive sack. Step 935 includes releasing the braid within the aneurysm and withdrawing the delivery tube and the microcatheter from the aneurysm and the vasculature.
  • It is understood that variations of the braid 10 can include various materials such as nitinol, stainless steel, bio absorbable materials, and polymers. Braid 10, including any specific portions such as any breaks and corresponding sacks, can be heat set to various configurations such as spherical, oblong, saddle shaped, etc. for the purpose of shaping the initial sack to better match the aneurysm morphology. In addition, the braid 10 can be heat shaped to include weak points to facility the braid buckling once it reaches the dome of the aneurysm. It is also understood that any sack formed by the herein discussed braids 10 can be in a spherical shape as depicted or any other shape, as needed or required, such as ellipsoidal, heart-shaped, ovoid, cylindrical, hemispherical, or the like. Further, interstices of braid 10 that form the sack can vary, or be selectively designed, in size or shape along its length depending on how much braid 10 is caused to radially expand as delivery tube 30 is distally moved.
  • The specific configurations, choice of materials and the size and shape of various elements can be varied according to particular design specifications or constraints requiring a system or method constructed according to the principles of the disclosed technology. Such changes are intended to be embraced within the scope of the disclosed technology. The presently disclosed embodiments, therefore, are considered in all respects to be illustrative and not restrictive. It will therefore be apparent from the foregoing that while particular forms of the disclosure have been illustrated and described, various modifications can be made without departing from the spirit and scope of the disclosure and all changes that come within the meaning and range of equivalents thereof are intended to be embraced therein.

Claims (18)

What is claimed is:
1. An occlusive device for treating an aneurysm, comprising:
a delivery system; and
a braid being slideably disposed within a microcatheter in a collapsed state, the braid having a distal end opposite a proximal end, the braid comprising a distal segment between the distal and proximal ends;
the braid configured to distally translate from within the microcatheter to a deployed state,
the braid configured to radially expand to the deployed state as the distal end of the braid exits the microcatheter thereby causing the distal segment to form an occlusive sack for the aneurysm disposed across the aneurysm neck,
the distal segment comprising a porosity that is reduced relative to the occlusive sack configured to thereby reduce flow velocity into the aneurysm; and
the braid being configured so that distally translating the proximal end of the braid a first distance from outside the aneurysm as the distal sack is forming inside the aneurysm causes the proximal end of the distal segment to invert then buckle inside the aneurysm so that the proximal end tucks one or more segments proximal of the distal segment into the occlusive sack.
2. The device of claim 1, the braid further comprising:
a tapered segment disposed between the distal segment and a proximal segment, the proximal segment being disposed on or adjacent the proximal end of the braid; and
a buckle portion between the distal segment and the tapered segment.
3. The device of claim 2, the proximal end of the braid configured to be overlaid internal to the occlusive sack of the distal segment by being inverted and buckled at the buckle portion after the occlusive sack of the distal segment has formed by radially expanding.
4. The device of claim 1, the distal segment comprises a higher braid angle relative to the occlusive sack.
5. The device of claim 1, the one or more segments proximal the distal segment comprise an increased braid angle relative to a braid angle of the distal segment.
6. The device of claim 1, the distal end of the braid being opened.
7. The device of claim 1, the distal segment of the occlusive sack being empty of filling material.
8. The device of claim 1, the braid being detachable from the delivery system in the aneurysm, the delivery system comprising:
a delivery tube comprising a distal end and a proximal end, the distal end of the delivery tube being detachably connected to the proximal end of the braid, the delivery tube being translatably disposable within a microcatheter;
the delivery tube configured to distally translate the braid within the microcatheter from the collapsed state to the deployed state.
9. The device of claim 8, the braid further comprising:
a tapered segment disposed between the distal segment and a proximal segment, the proximal segment being disposed on or adjacent the proximal end of the braid;
the occlusive sack of the distal segment being spherical and capable of sealing the neck of the aneurysm.
10. The device of claim 9, the distal segment configured to expand to form the occlusive sack as the distal end of the braid is distally translated away from the delivery tube.
11. The device of claim 9, the proximal segment attaches the braid to the distal end of the delivery tube and, after the distal segment has expanded to form the occlusive sack, the proximal segment is further configured to initiate inversion and buckling of the proximal end of the braid overlaid into the occlusive sack of the distal segment.
12. The device of claim 9, wherein the occlusive sack of the distal segment is a collapsible cage-like vaso-occlusive structure.
13. The device of claim 9, wherein the distal segment comprises fewer wire segments than the tapered and proximal segments.
14. The device of claim 9, the tapered segment configured to divert flow as the distal segment forms the occlusive sack adjacent or is against a wall of the aneurysm and the proximal segment inverts and buckles into the distal segment at the neck of the aneurysm.
15. A braid capable of moving from a collapsed state within a microcatheter to a deployed state distal to the microcatheter, comprising:
a proximal segment on or adjacent a proximal end;
a distal segment on or adjacent a distal end; and
a tapered segment between the distal segment and the proximal segment;
the braid configured so that when the distal end is distal of the microcatheter the distal segment is configured to radially expand and form an outer occlusive sack disposed across the aneurysm neck, the distal segment comprising a porosity that is reduced relative to the occlusive sack and configured to induce a flow diverting effect into the aneurysm, the occlusive sack having a diameter greater than the microcatheter;
the braid being configured so that distally translating the proximal end of the braid a first distance from outside the aneurysm as the distal sack is forming inside the aneurysm causes the proximal end of the distal segment to invert then buckle inside the aneurysm so that the proximal end tucks one or more segments proximal of the distal segment into the occlusive sack.
16. The braid of claim 15, the braid further comprising a buckle portion between the distal segment and the tapered segment, the buckle portion causing the proximal end of the braid to buckle into the occlusive sack
17. The braid of claim 15, the braid further comprising a buckle portion between the distal segment and the proximal segment, the buckle portion causing the proximal end of the braid to buckle into the occlusive sack.
18. The braid of claim 15, a braid angle of the tapered segment being reduced compared to a braid angle of the distal segment.
US16/924,571 2017-12-22 2020-07-09 Aneurysm device and delivery system Abandoned US20200337710A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/924,571 US20200337710A1 (en) 2017-12-22 2020-07-09 Aneurysm device and delivery system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/852,887 US10716574B2 (en) 2017-12-22 2017-12-22 Aneurysm device and delivery method
US16/924,571 US20200337710A1 (en) 2017-12-22 2020-07-09 Aneurysm device and delivery system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/852,887 Continuation US10716574B2 (en) 2017-12-22 2017-12-22 Aneurysm device and delivery method

Publications (1)

Publication Number Publication Date
US20200337710A1 true US20200337710A1 (en) 2020-10-29

Family

ID=64746170

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/852,887 Active 2038-04-17 US10716574B2 (en) 2017-12-22 2017-12-22 Aneurysm device and delivery method
US16/924,571 Abandoned US20200337710A1 (en) 2017-12-22 2020-07-09 Aneurysm device and delivery system

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/852,887 Active 2038-04-17 US10716574B2 (en) 2017-12-22 2017-12-22 Aneurysm device and delivery method

Country Status (13)

Country Link
US (2) US10716574B2 (en)
EP (1) EP3501428B1 (en)
JP (1) JP7317499B2 (en)
KR (1) KR20190076915A (en)
CN (1) CN109984800A (en)
AU (1) AU2018282472A1 (en)
BR (1) BR102018076836A2 (en)
CA (1) CA3028424A1 (en)
ES (1) ES2880405T3 (en)
IL (1) IL263829A (en)
MX (1) MX2019000233A (en)
RU (1) RU2018145543A (en)
TW (1) TW201934087A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11957356B2 (en) 2022-02-24 2024-04-16 NV MEDTECH, Inc. Methods and apparatus for stent assisted aneurysm coiling

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11583289B2 (en) 2008-05-01 2023-02-21 Aneuclose Llc Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation
US12004750B2 (en) 2008-05-01 2024-06-11 Aneuclose Llc Methods for creating an expandable two-part intrasacular aneurysm occlusion device from a tubular mesh
US11471164B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant
US11464518B2 (en) 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US11357511B2 (en) 2008-05-01 2022-06-14 Aneuclose Llc Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
EP3261703A4 (en) 2015-02-25 2018-10-24 Galaxy Therapeutics, LLC System for and method of treating aneurysms
KR20190115474A (en) * 2017-02-23 2019-10-11 디퍼이 신테스 프로덕츠, 인코포레이티드 Aneurysm device and delivery system
US11185335B2 (en) 2018-01-19 2021-11-30 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) * 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) * 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11602350B2 (en) * 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US12102327B2 (en) 2019-05-25 2024-10-01 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11058431B2 (en) 2019-05-25 2021-07-13 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
DE102019121546B4 (en) * 2019-08-09 2024-02-08 Acandis Gmbh Medical set and medical system for the treatment of aneurysms
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
DE102020118301A1 (en) * 2019-12-23 2021-06-24 Femtos Gmbh Implant for the treatment of aneurysms
US20220031334A1 (en) * 2020-07-31 2022-02-03 Covidien Lp Expandable devices for treating body lumens
US20220087681A1 (en) * 2020-09-23 2022-03-24 DePuy Synthes Products, Inc. Inverting braided aneurysm implant with dome feature
CN112656477B (en) * 2020-12-31 2023-06-20 杭州德诺脑神经医疗科技有限公司 Aneurysm occlusion device and microcatheter therefor
WO2022164957A1 (en) 2021-01-27 2022-08-04 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
CN113017950A (en) * 2021-02-08 2021-06-25 北京联合大学 Hemispherical braided stent and manufacturing method thereof
CN116831679B (en) * 2023-09-02 2023-11-14 杭州亿科医疗科技有限公司 Aneurysm vortex device easy to release

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050251200A1 (en) * 2002-08-29 2005-11-10 Stephen Porter Device for closure of a vascular defect and method for treating the same
US20140135812A1 (en) * 2012-11-13 2014-05-15 Covidien Lp Occlusive devices
US20150374483A1 (en) * 2013-03-15 2015-12-31 Insera Therapeutics, Inc. Vascular treatment devices and methods
US20160249934A1 (en) * 2013-08-16 2016-09-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US20180374483A1 (en) * 2017-06-21 2018-12-27 Saida Ashley Florexil Interpreting assistant system

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168622B1 (en) 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US7410482B2 (en) 1998-09-04 2008-08-12 Boston Scientific-Scimed, Inc. Detachable aneurysm neck bridge
US6391037B1 (en) 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
BE1016067A3 (en) 2004-06-03 2006-02-07 Frid Noureddine Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT.
EP1827250B1 (en) * 2004-08-31 2018-05-16 Cook Medical Technologies LLC Device for treating an aneurysm
EP1804719A2 (en) 2004-09-22 2007-07-11 Lee R. Guterman Cranial aneurysm treatment arrangement
EP1827251B8 (en) 2004-11-09 2013-12-11 Stryker Corporation Vaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion
US20080281350A1 (en) 2006-12-13 2008-11-13 Biomerix Corporation Aneurysm Occlusion Devices
US9232992B2 (en) 2008-07-24 2016-01-12 Aga Medical Corporation Multi-layered medical device for treating a target site and associated method
US8758423B2 (en) 2009-06-18 2014-06-24 Graftcraft I Goteborg Ab Device and method for treating ruptured aneurysms
WO2011057002A2 (en) 2009-11-05 2011-05-12 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
CA2812012C (en) 2010-09-10 2018-01-02 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US20120283768A1 (en) 2011-05-05 2012-11-08 Sequent Medical Inc. Method and apparatus for the treatment of large and giant vascular defects
US8764787B2 (en) 2011-06-17 2014-07-01 Aga Medical Corporation Occlusion device and associated deployment method
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
US20130204351A1 (en) 2012-02-02 2013-08-08 Inceptus Medical LLC Aneurysm Graft Devices And Methods
US10342546B2 (en) 2013-01-14 2019-07-09 Microvention, Inc. Occlusive device
CN108433769B (en) 2013-03-15 2021-06-08 柯惠有限合伙公司 Occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
WO2015160721A1 (en) 2014-04-14 2015-10-22 Sequent Medical Inc. Devices for therapeutic vascular procedures
BR102014014407A2 (en) 2014-06-12 2016-04-19 Biocelere Agroindustrial Ltda expression cassette to transform eukaryotic cell, genetically modified micro-organism with efficient xylose consumption, process for biofuel and biochemical production and biofuel and / or biochemical thus produced
EP3171793B1 (en) 2014-08-14 2024-07-24 Microvention, Inc. Filamentary devices for treatment of vascular defects
CN204683687U (en) 2015-04-15 2015-10-07 中国人民解放军第二军医大学 A kind of intracranial aneurysm neck reconstructing device
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
JP7129336B2 (en) * 2016-02-10 2022-09-01 マイクロベンション インコーポレイテッド vascular occlusion device
KR20190115474A (en) 2017-02-23 2019-10-11 디퍼이 신테스 프로덕츠, 인코포레이티드 Aneurysm device and delivery system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050251200A1 (en) * 2002-08-29 2005-11-10 Stephen Porter Device for closure of a vascular defect and method for treating the same
US20140135812A1 (en) * 2012-11-13 2014-05-15 Covidien Lp Occlusive devices
US20150374483A1 (en) * 2013-03-15 2015-12-31 Insera Therapeutics, Inc. Vascular treatment devices and methods
US20160249934A1 (en) * 2013-08-16 2016-09-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US20180374483A1 (en) * 2017-06-21 2018-12-27 Saida Ashley Florexil Interpreting assistant system

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11389174B2 (en) 2014-04-30 2022-07-19 Cerus Endovascular Limited Occlusion device
US12029431B2 (en) 2014-04-30 2024-07-09 Stryker Ireland Technology, Ltd. Occlusion device
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US12076022B2 (en) 2015-12-07 2024-09-03 Stryker Ireland Technology Ltd. Occlusion device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11957356B2 (en) 2022-02-24 2024-04-16 NV MEDTECH, Inc. Methods and apparatus for stent assisted aneurysm coiling

Also Published As

Publication number Publication date
EP3501428B1 (en) 2021-04-28
RU2018145543A (en) 2020-06-22
AU2018282472A1 (en) 2019-07-11
BR102018076836A2 (en) 2019-07-02
US10716574B2 (en) 2020-07-21
CA3028424A1 (en) 2019-06-22
JP2019111342A (en) 2019-07-11
IL263829A (en) 2019-03-31
CN109984800A (en) 2019-07-09
MX2019000233A (en) 2019-09-04
ES2880405T3 (en) 2021-11-24
JP7317499B2 (en) 2023-07-31
US20190192168A1 (en) 2019-06-27
TW201934087A (en) 2019-09-01
EP3501428A1 (en) 2019-06-26
KR20190076915A (en) 2019-07-02

Similar Documents

Publication Publication Date Title
US20200337710A1 (en) Aneurysm device and delivery system
US10939915B2 (en) Aneurysm device and delivery system
US11672540B2 (en) Aneurysm device and delivery system
US11058430B2 (en) Aneurysm device and delivery system
US11596412B2 (en) Aneurysm device and delivery system
US20200375607A1 (en) Aneurysm device and delivery system
US20200375606A1 (en) Aneurysm method and system
JP2019126734A5 (en)
US20210338247A1 (en) Double layer braid

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LORENZO, JUAN;GOROCHOW, LACEY;SOTO DEL VALLE, ARIEL;SIGNING DATES FROM 20181218 TO 20190807;REEL/FRAME:053163/0438

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION